ALLIANCE PHARMA PLC

Director's Dealing • Nov 12, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1014H

Alliance Pharma PLC

12 November 2018

12 November 2018

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Director Share Dealing

Alliance Pharma plc (AIM: APH), the international specialty pharmaceutical group, announces that it was notified on 9 November 2018 that, on the same day, John Dawson, Non-Executive Director, sold 1,100,000 ordinary shares of 1 pence each in the Company at a price of 70.1 pence per share.

Following this transaction, Mr Dawson's total interest in the Company is 55,476,402 ordinary shares, representing approximately 10.71 per cent of the Company's current issued share capital (comprised of a total beneficial interest in 35,476,402 Ordinary Shares, representing 6.85 per cent of the issued share capital, and a total non-beneficial interest in 20,000,000 Ordinary Shares, representing 3.86 per cent of the issued share capital).

For further information:

Alliance Pharma plc	+ 44 (0)1249 466966
Peter Butterfield, Chief Executive Officer
Andrew Franklin, Chief Financial Officer
www.alliancepharma.co.uk
Buchanan	+ 44 (0)20 7466 5000
Mark Court / Sophie Wills / Gemma Mostyn-Owen
Numis Securities Limited	+ 44 (0)20 7260 1000
Nominated Adviser: Michael Meade / Freddie Barnfield
Corporate Broking: James Black

Investec Bank plc	+ 44 (0)  20 7597 5970
Corporate Finance: Daniel Adams / Ed Thomas
Corporate Broking: Patrick Robb / David Herring

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by person discharging managerial responsibilities and persons closely associated with them.

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Mr John Dawson
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Alliance Pharma plc
b)	Legal Entity Identifier	213800RYIWZA4Q5WPZ13
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1.0 pence each ISIN: GB0031030819
b)	Nature of the transaction	Sale of shares
c)	Currency	GBP
d)	Price(s) and volume(s)	Price (p)	Volume(s)
70.1p	1,100,000
e)	Aggregated information - Aggregated volume - Price - Aggregated total	1,100,000 ordinary shares 70.1p £770,720.01
f)	Date of the transaction	9 November 2018
g)	Place of the transaction	London Stock Exchange, AIM

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHFKBDQPBDDFDD